Curis | CRIS - Interest Expense On Debt


Curis reported $178K in Interest Expense on Debt for its fiscal quarter ending in December of 2023.





Interest Expense On Debt Change Date
Alaunos Therapeutics USD 1.07M 215K Jun/2023
Amgen USD 653M 32M Dec/2025
AstraZeneca USD 484M 181M Dec/2025
Bayer EUR 675M 87M Dec/2025
Bristol-Myers Squibb USD 432M 48M Dec/2025
CSL USD 215M 111M Dec/2025
Curis USD 178K 441K Dec/2023
Eli Lilly USD 114.7M 134.3M Sep/2025
Exelixis USD 23.4M 3.9M Sep/2023
Gilead Sciences USD 255M 1000K Dec/2025
GlaxoSmithKline GBP 188M 21M Dec/2025
Incyte USD 582K 10K Dec/2025
Merck USD 412M 85M Dec/2025
Novartis USD 304M 23M Dec/2025
Pfizer USD 711M 59M Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR -25M 252M Dec/2025
Takeda JPY 123.63B 40.49B Dec/2025
TG Therapeutics USD 6.53M 187K Dec/2025
Verastem USD 1.15M 10K Sep/2024
Xoma USD 3.4M 150K Jun/2024